SecBot SecBot
SC 13G/A ·Filed Nov 5, 2026

ARWR

ARROWHEAD PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 12h ago SEC0000315066-26-002702
Passive stake amendment
Actionable Insight • Neutral

FMR LLC's passive stake update shows no material change in position or intent. Monitor next 13F filing for any shift in Fidelity's aggregate ARWR holdings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$57.46
T+0 close · Nov 5, 2026 · via day close
Latest settled
−17.94%
T+5 · $47.15
Vs SPY
−21.23%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $57.46entry
  2. T+1 · 11d ago +1.22%α +0.91% · $58.16
  3. T+5 · 5d ago −17.94%α −21.23% · $47.15
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 9,307,349 shares of Arrowhead Pharmaceuticals common stock as of September 30, 2026, representing 6.6% of shares outstanding. This is a routine passive stake update with no change in investment intent.

Key Financial Metrics

Stake
6.6%
Investor
FMR LLC
Investor Type
mutual fund

Key Facts

  • FMR LLC reports 9,307,349 shares of ARWR common stock as of September 30, 2026
  • Stake represents 6.6% of shares outstanding
  • Filing is an amendment to Schedule 13G, confirming passive investment intent
  • Filing made under Rule 13d-1(b), indicating ordinary course investment activity

Financial Impact

FMR LLC holds 9,307,349 shares valued at approximately $615 million based on $8.4B market cap and 6.6% stake

Risk Factors

  • No material risks identified from this routine passive filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000315066-26-002702
Document: 0000315066-26-002702-index-headers.html0000315066-26-002702
Document: 0000315066-26-002702-index.html0000315066-26-002702
Document: 0000315066-26-002702.txt0000315066-26-002702

Track record

7 reports on ARWR

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +17.69% at T+5 after the Nov 2, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Bearish 6/10 Entry $47.78 to $44.21 Now $44.21 +7.47% ▲ +7.47% +5.56% vs SPY
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $57.46 to $58.16 Now $44.21 −23.06% ▲ +1.22% +0.91% vs SPY
  3. Nov 4, 202612d ago 8-K Bullish 5/10 Entry $61.65 to $57.46 Now $44.21 −28.29% ▼ −6.80% −2.39% vs SPY
  4. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $59.53 to $61.65 Now $44.21 +25.73% ▼ −3.56% −1.91% vs SPY
  5. Sep 10, 20269w ago Institutional Cluster Mixed 5/10 Entry $82.76 to $82.85 Now $44.21 −46.58% ▲ +0.11% −0.74% vs SPY
  6. Aug 20, 202612w ago Insider Cluster Neutral 2/10 Entry $87.11 to $86.73 Now $44.21 −49.25% ▼ −0.44% −0.14% vs SPY
  7. Jun 16, 202621w ago 8-K Neutral 2/10 Entry $81.04 to $81.82 Now $44.21 −45.45% ▲ +0.96% +0.18% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 7h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026